Fuentes-Exposito MA, Frid S, Munoz-Mateu M, Siso-Almirall A, et al. Feasibility of the Xemio app for breast cancer survivors in a clinical setting:
Adherence, acceptance, and side effect monitoring (CTCAE vs. QoL). PLoS One 2026;21:e0342702.
PMID: 42127092
|